CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma

被引:19
|
作者
Zhou, Fenfang [1 ]
Shen, Dexin [1 ]
Xiong, Yaoyi [1 ]
Cheng, Songtao [1 ]
Xu, Huimin [1 ]
Wang, Gang [2 ,3 ,4 ]
Qian, Kaiyu [2 ,3 ,4 ]
Ju, Lingao [2 ,3 ]
Zhang, Xinhua [1 ]
机构
[1] Wuhan Univ, Dept Urol, Zhongnan Hosp, Wuhan, Peoples R China
[2] Wuhan Univ, Dept Biol Repositories, Zhongnan Hosp, Wuhan, Peoples R China
[3] Human Genet Resource Preservat Ctr Hubei Prov, Wuhan, Peoples R China
[4] Wuhan Univ, Lab Precis Med, Zhongnan Hosp, Wuhan, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2021年 / 10卷
基金
中国国家自然科学基金;
关键词
collagen triple helix repeat containing 1 (CTHRC1); kidney renal clear cell carcinoma; kidney renal papillary cell carcinoma; prognosis; immune infiltration;
D O I
10.3389/fonc.2020.570819
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Kidney renal clear cell carcinoma (KIRC) and kidney renal papillary cell carcinoma (KIRP) are the most common RCC types. RCC has high immune infiltration levels, and immunotherapy is currently one of the most promising treatments for RCC. Collagen triple helix repeat containing 1 (CTHRC1) is an extracellular matrix protein that regulates tumor invasion and modulates the tumor microenvironment. However, the association of CTHRC1 with the prognosis and tumor-infiltrating lymphocytes of KIRP and KIRC has not been reported. We examined the CTHRC1 expression differences in multiple tumor tissues and normal tissues via exploring TIMER, Oncomine, and UALCAN databases. Then, we searched the Kaplan-Meier plotter database to evaluate the correlation of CTHRC1 mRNA level with clinical outcomes. Subsequently, the TIMER platform and TISIDB website were chosen to assess the correlation of CTHRC1 with tumor immune cell infiltration level. We further explored the causes of aberrant CTHRC1 expression in tumorigenesis. We found that CTHRC1 level was significantly elevated in KIRP and KIRC tissues relative to normal tissues. CTHRC1 expression associates with tumor stage, histology, lymph node metastasis, and poor clinical prognosis in KIRP. The CTHRC1 level correlates to tumor grade, stage, nodal metastasis, and worse survival prognosis. Additionally, CTHRC1 is positively related to different tumor-infiltrating immune cells in KIRP and KIRC. Moreover, CTHRC1 was closely correlated with the gene markers of diverse immune cells. Also, high CTHRC1 expression predicted a worse prognosis in KIRP and KIRC based on immune cells. Copy number variations (CNV) and DNA methylation might contribute to the abnormal upregulation of CTHRC1 in KIRP and KIRC. In conclusion, CTHRC1 can serve as a biomarker to predict the prognosis and immune infiltration in KIRP and KIRC.
引用
收藏
页数:14
相关论文
共 50 条
  • [31] TACC3 is a prognostic biomarker for kidney renal clear cell carcinoma and correlates with immune cell infiltration and T cell exhaustion
    Fan, Xiaoyan
    Liu, Boyi
    Wang, Zhiyu
    He, Dongwei
    AGING-US, 2021, 13 (06): : 8541 - 8562
  • [32] Papillary renal cell carcinoma in allograft kidney
    Roy, C
    El Ghali, S
    Buy, X
    Lindner, V
    Gangi, A
    EUROPEAN RADIOLOGY, 2005, 15 (04) : 661 - 665
  • [33] Papillary renal cell carcinoma in allograft kidney
    Catherine Roy
    Sofiane El Ghali
    Xavier Buy
    Véronique Lindner
    Afshin Gangi
    European Radiology, 2005, 15 : 661 - 665
  • [34] Papillary Renal Cell Carcinoma in the Horseshoe Kidney
    Ying-Long, Sa
    Yue-Min, Xu
    Hong, Xie
    Xiao-Lin, Xu
    SOUTHERN MEDICAL JOURNAL, 2010, 103 (12) : 1272 - 1274
  • [35] TBC1D3 family is a prognostic biomarker and correlates with immune infiltration in kidney renal clear cell carcinoma
    Wang, Bei
    Chen, Dandan
    Hua, Haiying
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 22 : 528 - 538
  • [36] CLEAR CELL PAPILLARY RENAL CELL CARCINOMA: MICRORNA EXPRESSION PROFILING AND COMPARISON WITH CLEAR CELL RENAL CELL CARCINOMA AND PAPILLARY RENAL CELL CARCINOMA
    Munari, Enrico
    Marchionni, Luigi
    Chitre, Apurva
    Hayashi, Masamichi
    Martignoni, Guido
    Brunelli, Matteo
    Gobbo, Stefano
    Argani, Pedram
    Allaf, Mohamad
    Hoque, Mohammad
    Netto, George
    JOURNAL OF UROLOGY, 2014, 191 (04): : E244 - E244
  • [37] Clear Cell Papillary Renal Cell Carcinoma: microRNA Expression Profiling and Comparison with Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma
    Munari, E.
    Marchionni, L.
    Chitre, A.
    Hayashi, M.
    Martignoni, G.
    Brunelli, M.
    Gobbo, S.
    Argani, P.
    Allaf, M.
    Hoque, M. O.
    Netto, G. J.
    MODERN PATHOLOGY, 2014, 27 : 250A - 250A
  • [38] Gene expression profiling of clear cell papillary renal cell carcinoma: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma
    Fisher, Kevin E.
    Yin-Goen, Qiqin
    Alexis, Dianne
    Sirintrapun, Joseph S.
    Harrison, William
    Isett, R. Benjamin
    Rossi, Michael R.
    Moreno, Carlos S.
    Young, Andrew N.
    Osunkoya, Adeboye O.
    MODERN PATHOLOGY, 2014, 27 (02) : 222 - 230
  • [39] Clear Cell Papillary Renal Cell Carcinoma: microRNA Expression Profiling and Comparison with Clear Cell Renal Cell Carcinoma and Papillary Renal Cell Carcinoma
    Munari, E.
    Marchionni, L.
    Chitre, A.
    Hayashi, M.
    Martignoni, G.
    Brunelli, M.
    Gobbo, S.
    Argani, P.
    Allaf, M.
    Hoque, M. O.
    Netto, G. J.
    LABORATORY INVESTIGATION, 2014, 94 : 250A - 250A
  • [40] DNA methylation of Hugl-2 is a prognostic biomarker in kidney renal clear cell carcinoma
    Miao, Yi
    Cao, Fang
    Li, Pingping
    Liu, Peijun
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2021, 48 (01) : 44 - 53